New Zealand markets closed

Genmab A/S (GMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
29.69-0.25 (-0.84%)
At close: 04:00PM EDT
29.75 +0.06 (+0.20%)
Pre-market: 04:43AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close29.94
Open29.97
Bid31.62 x 800
Ask31.63 x 1100
Day's range29.67 - 30.01
52-week range26.32 - 42.99
Volume407,084
Avg. volume645,148
Market cap19.455B
Beta (5Y monthly)0.76
PE ratio (TTM)30.93
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Insider Monkey

    30 Biggest Biotechnology Companies in the World

    In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]

  • Insider Monkey

    Genmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript

    Genmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript February 14, 2024 Genmab A/S misses on earnings expectations. Reported EPS is $0.14 EPS, expectations were $0.35. Genmab A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you […]

  • GuruFocus.com

    Genmab: Growth Is Still a Better Choice

    A closer look at one of the leaders in the development of anti-cancer drugs